Literature DB >> 592332

Analogues of sparteine. 5. Antiarrhythmic activity of selected N,N'-disubstituted bispidines.

P C Ruenitz, C M Mokler.   

Abstract

A series of seven N,N'-disubstituted bispidines, structurally analogous to the inner (B and C) rings of sparteine (1) and encompassing a range of lipophilicity in which 1 was centered, has been compared to 1 in regard to antiarrhythmic potency and acute toxicity. Several of the bispidines were of comparable potency, and all but one were somewhat less toxic than 1. The ability of the mononitrate salts of 1 and bispidines 6 and 7 to bind calcium and magnesium cations in Me2SO-d6 solvent has been evaluated by proton magnetic resonance analysis. No binding could be demonstrated under these conditions, which suggested that pharmacologic effects of these compounds may be due to properties other than direct binding of these cations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 592332     DOI: 10.1021/jm00222a026

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.

Authors:  Christoph Eibl; Isabelle Tomassoli; Lenka Munoz; Clare Stokes; Roger L Papke; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2013-10-05       Impact factor: 3.641

2.  The Bispidinone Derivative 3,7-Bis-[2-(S)-amino-3-(1H-indol-3-yl)-propionyl]-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one Dihydrochloride Induces an Apoptosis-Mediated Cytotoxic Effect on Pancreatic Cancer Cells In Vitro.

Authors:  Melanie J Predebon; Danielle R Bond; Joshua Brzozowski; Helen Jankowski; Fiona Deane; Mark Tarleton; Aron A Shaw; Adam McCluskey; Michael C Bowyer; Judith Weidenhofer; Christopher J Scarlett
Journal:  Molecules       Date:  2019-01-31       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.